# World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)

> **NCT05215171** · — · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 100 (estimated)

## Conditions studied

- Cardiorespiratory and Vascular Dysfunction
- Obstructive Airway Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05215171
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-30
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05215171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05215171, "World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05215171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
